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The Hereditary Spastic Paraplegia Gene, spastin,
Regulates Microtubule Stability
to Modulate Synaptic Structure and Function
provide insight into neurological disorders linked to mi-
crotubule dysfunction.
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Hereditary Spastic Paraplegia (HSP) disease causesVanderbilt University
dysfunction in the corticospinal tract, causing progres-Nashville, Tennessee 37235
sive weakness and spasticity in the lower extremities2 Department of Pharmacology
[1]. The age of HSP onset ranges from the first to theDulbecco Telethon Institute
sixth decade, and symptoms also range widely in HSPFondazione Telethon
patients, making clinical data difficult to interpret. HSPUniversity of Padova
inheritance has been linked to at least 20 genetic loci [1],Padova, 35131
but less than half of these genes have been molecularlyItaly
identified. The characterized HSP-linked genes encode3 Eugenio Medea Scientific Institute
a diverse range of products, including cell adhesionConegliano Research Center
molecules (L1-CAM [2]), myelination proteins (DM20,Conegliano, 31015
PLP [3]), and microtubule motor proteins (KIF5A; [4]).Italy
However, approximately 40% of HSP disease cases are
linked to mutations of the SPG4 locus, which encodes
Spastin [5, 6]. Spastin is an ATPase that contains aSummary
microtubule-interacting domain [7], suggesting an ac-
tive role in cytoskeleton interactions. Interestingly, aBackground: Hereditary Spastic Paraplegia (HSP) is a
number of other HSP-linked genes have similar molecu-devastating neurological disease causing spastic weak-
lar features, including Spartin and Paraplegin [8–11].ness of the lower extremities and eventual axonal de-
In vitro experiments have confirmed that Spastin bindsgeneration. Over 20 genes have been linked to HSP
polymerized microtubules through its N terminus andin humans; however, mutations in one gene, spastin
demonstrate a requirement for Spastin ATPase activity(SPG4), are the cause of 40% of all cases. Spastin is a
to release it from microtubules [12]. These data suggestmember of the ATPases associated with diverse cellular
that Spastin normally plays some role involving the mi-activities (AAA) protein family, and contains a micro-
crotubule cytoskeleton in neurons. Loss of this Spastintubule interacting and organelle transport (MIT) domain.
function leads to progressive neuronal dysfunction, cul-Previous work in cell culture has proposed a role for
minating in axonal degeneration.Spastin in regulating microtubules.
Microtubules affect multiple facets of neuronal devel-Results: Employing Drosophila transgenic methods for
opment and function, with pronounced roles in growthoverexpression and RNA interference (RNAi), we have
cone motility and synaptic elaboration of both pre- andinvestigated the role of Spastin in vivo. We show that
postsynaptic structures being documented in a rangeDrosophila Spastin (D-Spastin) is enriched in axons and
of vertebrate and invertebrate systems [13–15]. The Dro-synaptic connections. At neuromuscular junctions (NMJ),
sophila neuromuscular junction (NMJ) synapse has beenDspastin RNAi causes morphological undergrowth and
a particularly useful genetic system in which to assayreduced synaptic area. Moreover, Dspastin overexpres-
the role of the microtubule cytoskeleton and model itssion reduces synaptic strength, whereas Dspastin RNAi
role in inherited neurological disease. For example, mu-elevates synaptic currents. By using antibodies against
tations in microtubule-interacting Futsch (MAP1b) andposttranslationally modified -Tubulin, we find that
VAP-33A alter synaptic morphology, thereby decreasingDspastin regulates microtubule stability. Functional syn-
bouton number and increasing bouton size [16–18].aptic defects caused by Dspastin RNAi and overexpres-
These data have produced the hypothesis that de-sion were pharmacologically alleviated by agents that
creased microtubule stability leads to growth and elabo-destabilize and stabilize microtubules, respectively.
ration of the presynaptic terminal [17]. In addition, theConclusions: Loss of Dspastin in Drosophila causes an
delivery of proteins and organelles required for neuro-aberrantly stabilized microtubule cytoskeleton in neu-
transmission, both pre- and postsynaptically, dependsrons and defects in synaptic growth and neurotransmis-
on microtubules and associated motor proteins [19–22].sion. These in vivo data strongly support previous re-
Acute pharmacological perturbation of microtubules atports, providing a probable cause for the neuronal
the Drosophila NMJ has not revealed major defects indysfunction in spastin-linked HSP disease. The role of
synaptic vesicle cycling [23]. On the other hand, lossSpastin in regulating neuronal microtubule stability sug-
or gain of expression studies of the Drosophila fragilegests therapeutic targets for HSP treatment and may
X-related (dfxr) gene have shown that it regulates Futsch
to cooperatively modulate both synaptic architecture*Correspondence: kendal.broadie@vanderbilt.edu (K.B.); daga@
and neurotransmission strength [14]. These studies indi-unipd.it (A.D.)
4 These authors contributed equally to this work. cate that microtubules play key functions in the control
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of synaptic structure and function and that mutations times into the Drosophila genome. UAS transgenes were
driven in tissue-specific patterns utilizing establishedperturbing microtubule dynamics are causatively linked
with inherited neurological disorders. GAL4 lines [26] including Tubulin-GAL4 (ubiquitous ex-
pression), Elav-GAL4 (nervous system-specific expres-It has recently been shown that Drosophila contains
a highly conserved spastin homolog (Dspastin) [24]. The sion; presynaptic at the NMJ), and Myosin heavy chain
(MHC)-GAL4 (muscle-specific expression; postsynapticDrosophila NMJ system therefore provides an attractive
opportunity to model HSP and to test the in vivo function at the NMJ) [25].
The efficacy of transgenic RNAi was assayed in twoof D-Spastin. Here, we show that Drosophila Spastin is
localized at the NMJ and specifically enriched in presyn- ways: (1) RT-PCR of total mRNA harvested from animals
expressing UAS-RNAi ubiquitously driven by the Tu-aptic boutons. The dosage of Dspastin was altered in a
targeted fashion in the nervous system with transgenic bulin-GAL4 driver, and (2) anti-D-Spastin immunocyto-
chemistry on animals expressing UAS-RNAi in tissue-RNA interference (RNAi) [25] and overexpression tech-
niques, and the consequence was assayed with elec- specific patterns, discussed below in greater detail.
Ubiquitous expression of the RNAi construct decreasestrophysiology and confocal imaging. Knockdown of
D-Spastin (i.e., reduction of Dspastin mRNA through Dspastin mRNA levels as assayed by RT-PCR (Figure
1A). Amplification of Dspastin mRNA in all control linesRNAi) in neurons results in synaptic undergrowth. Con-
versely, loss of D-Spastin in neurons causes much results in a robust product of the expected size (2 kB),
whereas UAS-RNAi; Tubulin-GAL4 individuals show nostronger neurotransmission, whereas D-Spastin overex-
pression weakens synaptic function. Microtubule stabil- detectable Dspastin mRNA band, but only a product
amplified from genomic DNA. This genomic fragmentity was assayed locally within the synapse by using
antibodies specific to modified Tubulin, which label contamination persists when template RNA is pre-
treated with DNase I and also appears when reversestable and long-lived microtubules. Knockdown of
D-Spastin results in accumulation of stabilized Tubulin, transcriptase is omitted from the RT-PCR reaction mix-
ture. These results indicate that the UAS-Dspastin-RNAiwhereas D-Spastin overexpression conversely reduces
stable microtubules. Direct pharmacological manipula- transgene effectively and specifically reduces Dspastin
mRNA.tion of microtubule stability, to counter the observed
defects, rescues the functional synaptic defects in both
classes of Dspastin mutant. Together, these data pro-
Drosophila Spastin Protein Is Enrichedvide the first in vivo evidence that Spastin regulates
at Synapsesmicrotubule stability and show that this function of
Spastin protein is highly enriched within the nervousSpastin strongly modulates both synaptic architecture
system of mammals [27]. Recent work has shown thatand neurotransmission strength.
the Dspastin message is similarly enriched in the ner-
vous system during Drosophila embryonic development
[24]. To determine the endogenous D-Spastin proteinResults
expression pattern at maturity and, in particular, to de-
fine the subcellular localization of D-Spastin protein inThe Drosophila spastin Gene: Transgenic
Manipulation of Expression neurons, we generated a polyclonal antibody against
Drosophila Spastin. The specificity of this antibody wasHuman spastin is comprised of several functional do-
mains, all of which are conserved in the Drosophila gene determined by Western blot analyses, which reveal a
band of the predicted size for D-Spastin (84 kDa; data[24]. Overall, Dspastin exhibits 48% identity and 60%
similarity at the amino acid level with the human homo- not shown). We focused specifically on D-Spastin ex-
pression in the larval neuromusculature (Figure 1B) bylog. Both human and Drosophila proteins contain a pre-
dicted transmembrane domain (40% identity), a microtu- using immunohistochemistry with the D-Spastin anti-
serum.bule interacting and organelle transport (MIT) domain
(55% identity) and an ATPases associated with diverse D-Spastin protein is present in the cytoplasm of both
neurons and muscles but is not detectably expressedcellular activities (AAA) domain (70% identity). The high
degree of conservation of these motifs suggests that in nuclei (Figure 1B). While the protein is present at a
low level throughout the neuromusculature, muscles,the function of Spastin has been tightly maintained
throughout evolution. and neuronal axons, D-Spastin is particularly enriched
at NMJs throughout the body-wall muscles (Figure 1C).In order to alter D-Spastin expression in a targeted
fashion within the nervous system, we constructed mul- NMJs on the well-characterized four ventral longitudinal
muscles (12, 13, 6 and 7) all exhibit similar levels oftiple, independent transgenic lines for both (1) the over-
expression of the wild-type protein, and (2) RNAi-medi- D-Spastin immunoreactivity. The protein appears en-
riched in punctate domains of synaptic boutons andated knockdown of the protein. For overexpression, the
Dspastin coding region was cloned downstream of the relatively excluded from interbouton axonal connec-
tives. Colabeling with D-Spastin (Figure 1C; green) andUAS responder element (UAS-Dspastin) and stably
transformed into the Drosophila genome to generate the integral synaptic vesicle protein Synaptotagmin (Fig-
ure 1C; red) indicates that D-Spastin colocalizes withmultiple, independent transgenic lines. For inducible
RNAi knockdown, a Dspastin cDNA fragment was fused the synaptic vesicle pools and is not appreciably con-
centrated outside of the presynaptic domain. Neuronal-with the corresponding genomic sequence as previously
described (see Experimental Procedures, [36]). This se- specific overexpression of D-Spastin with the Elav-
GAL4 driver greatly enhances NMJ protein expressionquence was then placed under the control of a UAS
promoter (UAS-RNAi) and stably transformed multiple and further emphasizes the protein enrichment specifi-
Modeling Spastic Paraplegia in Drosophila
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Figure 1. Transgenic RNAi Knockdown Dspastin Message and Protein in a Tissue-Specific Manner in the Nervous System
(A) RT-PCR showing loss of Dspastin mRNA after ubiquitous expression of the Dspastin RNAi transgene (RNAi). RNAi animals exhibit no
change of control cDNA expression (control; CG7263 gene; 1.8 kB band). Similarly Dspastin message (2.1 kB band) is not perturbed in the
UAS-RNAi/ (RNAi “”) control, but is undetectable in UAS-RNAi/; Tubulin-Gal4/ (RNAi “”) animals. A 3 kB band persists when reverse
transcriptase is omitted from the RT-PCR reaction mix and is reduced in the presence of DNaseI, indicating a putative genomic contaminant.
(B) Low magnification of a wandering third instar NMJ on muscles 6 and 7 (M6; M7) double labeled with anti-HRP (red), a neuronal marker
of innervation, and anti-D-Spastin (green). The motor nerve enters the focal plane from below (arrow) and then individual motor axons branch
along the muscle, forming numerous varicosities (synaptic boutons). D-Spastin protein is widely expressed in the cytoplasm of both muscles
and neurons, but nuclei (N) lack detectable D-Spastin immunoreactivity.
(C) D-Spastin localizes within NMJ synaptic boutons. Immunoreactivity of D-Spastin (green) compared to the integral synaptic vesicle protein
Synaptotagmin (red) in a wandering third instar NMJ (bottom row represents merged signals). The left column shows a genetic control (Elav-
GAL4/). Note that D-Spastin is concentrated within synaptic boutons, closely colocalizing with Synaptotagmin. Punctate D-Spastin is also
present in the muscle; the punctate nature of staining was variable. The middle column shows Dspastin overexpression specifically in the
nervous system (Elav-GAL4; UAS-Dspastin). Note the higher intensity of signal but that the restriction of D-Spastin to the synaptic bouton
compartment persists. The right column shows RNAi knockdown of D-Spastin specifically in the nervous system (Elav-GAL4; UAS-RNAi). The
D-spastin signal is lost in the NMJ boutons but persists in the muscle. Scale bar  20 m.
cally within presynaptic boutons (Figure 1C). Elav-GAL4 clusion, however, is that we are analyzing RNAi-medi-
ated knockdown of D-Spastin protein levels and not adriven Dspastin RNAi greatly reduces D-Spastin immu-
noreactivity at the NMJ, again suggesting that the pro- null Dspastin mutant. The highest levels of pan-neuronal
RNAi expression did not result in preadult lethality. How-tein is enriched only presynaptically and that the RNAi
transgene is effective in reducing protein levels (Fig- ever, animals expressing Dspastin RNAi in the nervous
system display compromised adult coordination and lo-ure 1C).
comotory behavior.
Transgenic overexpression of a number of indepen-The Dspastin Gene Is Essential,
and Overexpression Causes Cell Death dent UAS-Dspastin lines, driven either with ubiquitous or
neuronal GAL4 drivers, resulted in 100% lethality duringUbiquitous expression of Dspastin UAS-RNAi results in
pupal lethality, suggesting that Dspastin is an essential embryonic or very early larval stages (data not shown).
A single copy of the UAS-Dspastin transgene and agene (data not shown). An important caveat to this con-
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single copy of the GAL4 driver were sufficient to cause a suction electrode elicits large, highly reproducible glu-
tamate-gated synaptic currents in the voltage-clampedthis early lethality in most cases. Targeted expression
of UAS-Dspastin in subsets of the adult nervous system (60 mV) muscle (Figure 2C). All genetic control animals
exhibited indistinguishable mean excitatory junctional(the eye, for example) causes severe neurodegeneration
(data not shown). Given the deleterious effect of Dspas- current (EJC) amplitudes similar to wild-type in the range
of 81–86 nA (Figure 2D; Elav-GAL4/, 85.3  3.8; UAS-tin overexpression on neuronal viability, we selected
for further experiments a particularly weakly expressing Dspastin/, 86.5  5.8; UAS-RNAi/, 81.7  5.16; no
significant difference). These results show that the pres-UAS-Dspastin transgenic line that permits full viability
(expression shown in Figure 1C). ence of GAL4 driver or UAS transgenes alone does not
alter basal synaptic function. In contrast, altering the
D-Spastin level in the presynaptic terminal has dramaticLoss of Spastin Causes Synaptic Undergrowth
effects on synaptic efficacy (Figure 2C). Neural over-and Reduced Synaptic Area
expression of D-Spastin (Elav-GAL4; UAS-Dspastin)Previous in vitro studies indicate that mammalian Spas-
causes a highly significant reduction in mean EJC ampli-tin associates with microtubules [12]. Regulation of the
tude, down to 47.3  8.5 nA in mutants compared tomicrotubule cytoskeleton has been well documented
85.3  3.8 in control (p  0.005; Figures 2C and 2D).to control growth and elaboration of the presynaptic
On the contrary, loss of D-Spastin in neurons (Elav-terminal at the Drosophila NMJ [14, 16–18]. We therefore
GAL4; UAS-RNAi) had the opposite effect of increasingassayed synaptic morphology in Dspastin transgenic
synaptic currents by 50%. The mean EJC amplitudeanimals by confocal imaging with an antibody against
in RNAi lines is 138.9  17.3 compared to 85.3  3.8 inHRP to label neuronal membranes (Figure 2A) and calcu-
control (p  0.05; Figures 2C and 2D).lated the area of the synaptic region by using confocal
Axon length has been postulated as a cellular determi-software (see Experimental Procedures; Figure 2B).
nant for spastin-mediated neural dysfunction. We there-The overall morphology of the NMJ synapse was not
fore compared EJC amplitudes in an anterior abdominalsignificantly altered in any of the genetic control lines.
segment (A3, above) with a short motor nerve to EJCCalculation of synaptic terminal area at the muscle 6/7
amplitudes in a posterior segment (A6) with a muchNMJ showed 826  60 m2 in Elav-GAL4/ driver ani-
longer motor nerve. We predicted that the severity ofmals alone (Figure 2B; control), with similar synaptic
neurotransmission defects might correlate with motorareas in UAS-Dspastin/ (808  64 m2) and UAS-
axon length. In contrast to this prediction, we observedRNAi/ (679  67 m2) (no significant change; data
neurotransmission defects in A6 that were indistinguish-not shown). In contrast, neural-specific Dspastin RNAi
able from those in A3. In both cases, D-Spastin overex-expression causes a severe reduction of total synaptic
pression caused comparable suppression of neuro-area compared to all controls (Figure 2A). For example,
transmission, and Dspastin RNAi caused comparableat the muscle 6/7 NMJ, Dspastin RNAi (Elav-Gal4; UAS-
enhancement of neurotransmission (data not shown).RNAi) reduces the area of the presynaptic terminal by
Thus, within the limits of this system, we find no correla-50%, from 826  60 m2 in control to 429  67 m2
tion between axon length and the manifestation of Spas-in mutant (p  0.005; Figure 2B). Neural overexpression
tin-dependent alterations in synaptic efficacy or neuro-of D-Spastin conferred no significant effect on gross
transmission strength.synaptic area, with the overexpression line (Elav-GAL4;
UAS-Dspastin) exhibiting a mean area of 782  72 m2
compared to 808  64 m2 in controls (no significant Spastin Regulates Microtubule Stability
change). These data indicate that D-Spastin may play in the Presynaptic Terminal
a regulatory role in synaptic growth. In mammals, Spastin has been shown to dismantle the
microtubule cytoskeleton, with an activity similar to its
AAA-family relative, Katanin [12, 32]. We therefore exam-Presynaptic Neurotransmission Strength
Is Regulated by Spastin ined the capacity of D-Spastin to regulate microtubule
stability locally at the synapse by using anti-TubulinElectrophysiological studies of neural function in HSP
patients have been limited by the techniques available antibodies as well as antibodies specific for both acet-
ylated -Tubulin and glutamylated 	-Tubulin, posttrans-and small sample sizes [28]. Since D-Spastin localizes
to presynaptic boutons and regulates synaptic architec- lational modifications that occur only in structurally sta-
ble microtubules [33, 34]. Western analyses withture at the Drosophila NMJ, we next examined synaptic
function in animals with altered Dspastin dosage. This antibodies against each of these specific forms of Tu-
bulin reveal a single band of the predicted molecularglutamatergic NMJ has been the subject of extensive
morphological and physiological studies. Changes in weight, indicating specificity (data not shown).
The dosage level of D-Spastin appears to affect thesynaptic efficacy sometimes appear to compensate for
changes in synaptic area [29] and in other cases func- abundance and distribution of acetylated -Tubulin within
neurons. Neural-specific overexpression of D-Spastintional strength parallels changes in synaptic area [30,
31], and therefore the relationship between these pa- (Elav-GAL4; UAS-Dspastin) causes a reduction of acet-
ylated -Tubulin within neurons and specifically at NMJrameters is variable. We employed a two-electrode volt-
age-clamp recording configuration to record synaptic presynaptic terminals (Figure 3A; middle row). After
D-Spastin overexpression, bundled acetylated -Tubu-currents at the NMJ in animals with altered D-Spastin
expression specifically within the presynaptic terminal. lin in axons appears thinned and shortened and, often,
the stabilized Tubulin network is no longer detectableIn normal animals, stimulation of the motor nerve with
Modeling Spastic Paraplegia in Drosophila
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Figure 2. Dspastin Dosage Strongly Affects both NMJ Synapse Morphology and Function
(A) Representative images of the larval NMJ at muscles 6/7, the site of all functional studies, revealed with horseradish peroxidase (HRP; red)
immunocytochemistry. All genetic controls displayed similar elaborate, highly branched synaptic architecture (Elav-GAL4/ is shown). In
contrast, neural-specific Dspastin RNAi (Elav-GAL4/; UAS-RNAi) results in a greatly simplified synaptic arbor, containing fewer branches/
boutons and occupying a smaller synaptic area. Scale bar  20 m.
(B) Quantification of the synaptic area for the genotypes in (A). Neural expression of Dspastin RNAi causes a highly significant decrease in
synaptic area (p  0.005; n 
 5).
(C) Synaptic function is bidirectionally altered in response to changes in Dspastin dosage. Sample traces of excitatory junctional currents
(EJCs) from control (Elav-GAL4/), neural overexpression (Elav-GAL4; UAS-Dspastin), and neural RNAi (Elav-GAL4; UAS-RNAi) NMJ synapses.
The artifact preceding the glutamate-gated current represents the stimulation to the motor nerve.
(D) Quantification of mean EJC amplitude in the three genotypes. All genetic controls (Elav-GAL4/, UAS-Dspastin/, and UAS-Dspastin-
RNAi/) had indistinguishable neurotransmission. Driving overexpression of D-Spastin in neurons causes a significant decrease in EJC
amplitude. Neural RNAi causes a significant increase in EJC amplitude. All bars show mean  SEM; the asterisk indicates significance (p 
0.005; n 
 5).
within interbouton connectives of the NMJ. In contrast, It is difficult to resolve the fine structure of the microtu-
bule cytoskeleton within the presynaptic terminal itself.D-Spastin knockdown in the neuron (Elav-GAL4; UAS-
RNAi) results in an accumulation of acetylated -Tubulin We therefore expressed the Dspastin transgenes under
the control of the MHC-GAL4 driver to alter Dspastinwithin the neuron and specifically at the NMJ presynap-
tic terminal (Figure 3A, bottom row). Note that detector levels in the much larger muscle cells (Figure 3B). In
muscles, individual microtubules can be visualized bygain for the RNAi image in Figure 3A has been reduced
to 70% of that used to image the other genotypes to confocal imaging with Tubulin and acetylated -Tubulin
antibodies. These microtubules overlap in a loose mesh-avoid signal saturation. In the Dspastin RNAi lines, acet-
ylated -Tubulin immunoreactivity is more prominent in work, as opposed to microtubules in neurons, which are
arranged in parallel in long bundles (Figures 3A and 3B).the neuronal axon and within the NMJ (Figure 3A). After
Dspastin RNAi, stabilized microtubules form loops or Overexpression of D-Spastin in the muscle (MHC-GAL4;
UAS-Dspastin) results in a decrease in the acetylatedtwists in NMJ boutons, a rare feature in normal synaptic
boutons [16, 17]. These data suggest a role for Dspastin -Tubulin staining intensity (Figure 3B), suggesting that
microtubules are less stable. Although the effect is lessin destabilizing the microtubule cytoskeleton in neurons,
including synaptic bouton regions responsible for pre- than in the neuronal terminal, the number of acetylated
-Tubulin microtubules appears to be fewer and thesynaptic function during neurotransmission.
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Figure 3. D-Spastin Regulates the Stability of the Microtubule Cytoskeleton In Vivo
(A) Representative images of NMJ immunocytochemistry with an antibody specific to acetylated -Tubulin (green), present only in stable
microtubules, and -HRP (red), a neuronal maker of the presynaptic arbor. In control animals, stabilized microtubules are restricted to the
axons and the interbouton axonal connectives at the NMJ and do not enter the synaptic boutons. In the merged image, note the narrow
channel of stabile microtubules (green) threaded through the synaptic terminal bouton varicosities (red). In animals overexpressing Dspastin
only in the neuron (middle row; Elav-GAL4; UAS-Dspastin), the stabilized microtubules are specifically lost at the synaptic terminal. This loss
may be near complete (shown) or may manifest as a thinning/shortening of the microtubule signal (see Figure 4). In animals expressing
Dspastin RNAi in neurons (bottom row; Elav-GAL4; UAS-RNAi), there is a dramatic accumulation of stabilized microtubules. Note also in the
merged image that the microtubules now enter the synaptic boutons. The gain here is turned down to 0.7 relative to the other two genotypes.
Scale bar  10 m.
(B) D-Spastin levels are selectively regulated in muscle by using a muscle-specific MHC-GAL4 driver. The microtubules can be more clearly
visualized in these large syncitial cells as a mesh-like web (N  nucleus). A similar pattern of changed acetylated -Tubulin expression is
observed in muscle when following Dspastin overexpression and RNAi. Scale bar  10 m.
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density of the stabilized microtubule mesh is reduced disappearance, of stabilized microtubules; however, ex-
clusion of D-Spastin from interbouton connectives isthroughout the muscle cell. On the other hand, Dspastin
RNAi in muscles (MHC-GAL4; UAS-RNAi) has the oppo- maintained (Figure 5). In D-Spastin knockdown animals,
bundled microtubules appear more stable, more promi-site effect of increasing the acetylated -Tubulin stain-
ing intensity (Figure 3B), suggesting that microtubules nent, and take up more of the presynaptic compartment.
Subcellular compartments of the synaptic vesicle/have become more stable. Again the effect is less pro-
nounced than in the neuronal terminal, but there is a D-Spastin domain are distinct from the stabilized micro-
tubule domain in control animals (left column), while thisclear increase in the number of acetylated -Tubulin
microtubules, resulting in a thick mesh-like network compartmentalization is compromised with the loss of
D-spastin (right column; Figure 5). The bottom mergedthroughout the multinucleate muscle cell. These data
recapitulate the observations made in the NMJ and cor- row shows all three signals simultaneously. To quantify
these data we recorded mean pixel intensity for all threeroborate the notion that D-Spastin destabilizes microtu-
bules. channels within the Syt-positive region of the bouton
(see Experimental Procedures for details; all n  10To extend these studies in the synaptic terminal, we
next examined subcellular colocalization of total Tubulin boutons; Figure 5B). Control animals exhibit relative in-
tensities of 67.7%  5.2% for D-Spastin and 49.0% in colabeling studies with both postranslationally modi-
fied acetylated and glutamylated forms of Tubulin (Fig- 2.4% for acetylated Tubulin within synaptic boutons.
D-Spastin exhibits a quantifiable increase in synapticure 4). In control animals, total Tubulin immunoreactivity
is similar to modified forms, both in localization (Figures localization during overexpression (85.9%  5.1%) and
a corresponding decrease in intensity when RNAi is ex-4A and 4B) and intensity (Figure 4C). After normalizing
fluorescence intensity of microtubule signal to HRP sig- pressed in neurons (20.2%  3.1%). Acetylated Tubulin
immunoreactivity exhibits a complimentary patternnal intensity (see Experimental Procedures), we find no
significant quantifiable change between their immunore- compared to D-Spastin, showing increased intensity in
Syt bouton regions of RNAi expressing animalsactivities at wild-type synapses (Tubulin  40.6% 
2.3%, n  11; acetylated Tubulin  43.4%  5.1%, (71.6% 2.3%) and a reduction during D-Spastin neural
overexpression (30.7%  2.2%). These results suggestn  4; glutamylated Tubulin  48.2%  7.8%, n  5).
In overexpressing animals, signal intensities are signifi- that D-Spastin may play a role in spatially restricting
stabilized microtubules in the presynaptic terminal.cantly reduced for Tubulin (28.1%  4.9%, n  8, p 
0.01), glutamylated Tubulin (21.4%  5.2%, n  5, p 
0.05), and acetylated forms of Tubulin (28.3%  4.1%,
Synaptic Function Is Rescued by Restoringn  5, p  0.05) compared to fluorescence intensities
Microtubule Stabilityin control animals. Also consistent with previous obser-
The above results show that D-Spastin regulates synap-vations, neurons expressing D-Spastin RNAi exhibit in-
tic structure and function, and locally regulates the sta-creased levels of postranslationally modified forms of
bility of the microtubule cytoskeleton within the NMJTubulin (acetylated  74.7%  5.6%, n  8; glutamy-
synapse. We used a pharmacological approach to testlated  77.9%  5.8%, n  8). These changes are ac-
for a causal relationship between synaptic propertiescompanied by a reduction in total Tubulin immunoreac-
and microtubule stability. Tubulin monomers are stablytivity at the synapse (25.3 4.0%, n 11, p 0.01). This
polymerized by taxol while microtubules are rapidly dis-finding was unexpected, and was initially suspected to
assembled by nocodazole. Given the above results (Fig-be an artifact due to preferential binding of the modified
ures 3–5), taxol treatment should therefore counter theTubulin antisera competing with the Tubulin antibody.
effect of Dspastin overexpression, and nocodazoleHowever, by using a different Tubulin antisera, both
treatment should counter the effect of Dspastin RNAi.alone and coincubated with modified Tubulin antibod-
We acutely (1 hr) applied these pharmacologicalies, these observations were confirmed, suggesting that
agents on dissected larval preparations of these trans-reduced D-Spastin causes a dramatic decrease in the
genic animals and assayed their consequences on syn-amount of free Tubulin dimers unincorporated into fila-
aptic function (see Experimental Procedures for details).ments.
Similar approaches have provided verification of synap-As shown above, D-Spastin localizes to synaptic bou-
tic mechanisms in the Drosophila NMJ system [35].tons, colocalizing with the synaptic vesicle marker anti-
Previous studies have suggested that acute pharma-synaptotagmin (Figure 1C), and altering D-Spastin
cological treatment with drugs that alter microtubuledosage changes the stability of the microtubule cy-
dynamic instability dynamics does not significantly altertoskeleton within the presynaptic arbor (Figures 3 and
synaptic vesicle cycling at the wild-type NMJ [23]. Simi-4). To further visualize how D-Spastin regulates microtu-
larly, we found that treatment of control animals withbule stability at the synapse, we triple labeled individual
either taxol or nocodazole produced no significantNMJ presynaptic terminals with antibodies against Syn-
change in mean EJC amplitudes (data not shown). Neu-aptotagmin (red), D-Spastin (green), and acetylated
ral overexpression of D-Spastin causes decreased mi--Tubulin (blue) and examined the local synaptic do-
crotubule stability and decreased EJC amplitude. Thesemains in neurons following over- and underexpression
animals (Elav-GAL4; UAS-Dspastin) were therefore pre-of D-Spastin (Figure 5). In control animals, D-Spastin
treated with taxol to stabilize microtubules and thenlocalizes within synaptic boutons, subcellular regions
assayed for rescue of synaptic transmission. Taxol treat-where stable microtubules are absent, exhibiting re-
ment elevated EJC amplitudes from a mean of 23.1 duced acetylated Tubulin immunoreactivity. Overex-
pression of D-Spastin causes a thinning, and at times 6.5 nA in mock-treated animals to a mean of 49.8 
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Figure 4. Synaptic Localization of Total Tu-
bulin Is Influenced by D-Spastin Dosage
Individual NMJ synaptic boutons triple la-
beled with anti-horseradish peroxidase (red)
to reveal synaptic architecture, and antibody
to total Tubulin (green) and an antibody to
postranslationally modified forms of Tubulin
present only in stabilized microtubules (blue).
The three columns show the genetic control
(Elav-GAL4/, left), Dspastin overexpression
(Elav-GAL4/; UAS-Dspastin, middle), and
Dspastin RNAi (Elav-GAL4/; UAS-RNAi,
right).
(A) Acetylated -Tubulin immunoreactivity
(blue) is reduced in neurons overexpressing
D-Spastin while Dspastin RNAi causes an in-
crease in this signal. A similar pattern is ob-
served with the total Tubulin antibody (green).
(B) Glutamylated 	-Tubulin (blue) is similarly
reduced by D-Spastin neuronal overexpres-
sion and increased in response to Dspastin
RNAi; however, total Tubulin immunoreactiv-
ity is reduced in these animals. Scale bar 
5 m.
(C) Quantification of these data reveals statis-
tically significant changes in fluorescence in-
tensity relative to HRP signal intensity (see
Experimental Procedures for details on this
calculation).
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Figure 5. D-Spastin Locally Regulates Microtubule Stability in NMJ Presynaptic Terminals
(A) Triple labeling of the larval NMJ with antibodies specific for the integral synaptic vesicle protein Synaptotagmin (red), D-Spastin (green),
and acetylated -Tubulin (blue). In control animals, D-Spastin colocalizes with synaptic vesicle pools, regions devoid of stabilized microtubules.
These relative compartments are normally very tightly defined (see triple label merge at bottom). Additional D-Spastin protein (overexpression)
causes a reduction of the stabilized microtubules but only slightly perturbs this compartmentalization, leading to some spread of the Synaptotag-
min signal. Reduction of D-Spastin (neural specific Dspastin RNAi; a mild example selected here) dramatically perturbs functional compartments
in the synaptic arbor; stabilized microtubules invade synaptic boutons, and Synaptotagmin spreads through the interbouton connectives.
Scale bar  5 m.
(B) Quantification of these data demonstrates statistically significant changes in D-Spastin fluorescence intensity (green bars) and acetylated
Tubulin immunoreactivity (blue bars) relative to Synaptotagmin intensity in response to D-Spastin dosage changes (see Experimental Procedures
for details on this calculation; *p  0.05, **p  0.01; n 
 10 boutons and three synapses in all experiments).
8.7 nA in taxol-treated animals (Figures 6A and 6B; com- ically, conferring maximal effects on synaptic trans-
mission.pare red experimental to black control). RNAi-mediated
knockdown of D-Spastin causes increased microtubule
stability and increased EJC amplitude. These animals Discussion
(Elav-GAL4; UAS-RNAi) were therefore pretreated with
nocodazole to destabilize microtubules and then as- Mutations in the spastin (SPG4) gene are the leading
sayed for rescue of the EJC defect. Synaptic currents in cause of Hereditary Spastic Paraplegia (HSP), a progres-
mock-treated animals averaged 75.6  6.4 nA, whereas sively debilitating neurological disease characterized by
nocodazole-treatment decreased EJC amplitudes to dysfunction of corticospinal tract neurons, followed by
41.1  8.6, which is statistically indistinguishable from eventual axonal degeneration [1]. The Spastin protein
controls (Figures 6A and 6B; compare blue experimental is an ATPase that associates with microtubules in an
to white control). Converse pharmacological experi- ATP-dependent manner [7, 12], leading to the hypothe-
ments were also performed in an effort to enhance the sis that loss of Spastin may cause microtubule-related
microtubule stability phenotypes previously described. defects in neuronal function required for axonal mainte-
Taxol pretreatment in RNAi-expressing animals resulted nance. Drosophila has a single, highly conserved spastin
in a slight, but statistically irrelevant, change in synaptic homolog (Dspastin) containing both ATPase and micro-
currents (92.5 19.7 nA), suggesting that these animals tubule-interacting domains [24]. The Drosophila neuro-
are not sensitive to additionally stabilized microtubules. musculature has previously proven important for
D-Spastin-overexpressing animals exposed to noco- assaying microtubule mechanisms relevant to neuronal
doazole also exhibit no net change in EJC amplitudes function and neurological disease [14, 16–18], making
(27.7  4.4 nA) compared to mock-treated controls. it a logical choice for modeling the neurological role of
These data show that synaptic function can be rescued Spastin in vivo. We have used a targeted transgenic
by pharmacologically restoring, as appropriate, the sta- approach for RNAi knockdown and overexpression of
bility of microtubules in animals with altered levels of Spastin in the nervous system to assay the in vivo re-
neuronal D-Spastin and further suggest that these quirement for Spastin specifically in neurons.
Drosophila Spastin is widely expressed in many celltrangenic conditions cannot be enhanced pharmacolog-
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Figure 6. Pharmacological Rescue of Neuro-
transmission in Dspastin Mutant Synapses
(A) Representative traces of NMJ synaptic
currents after treatment with 50M taxol (red)
and 3 M nocodazole (blue). The artifact pre-
ceding the glutamate-gated current repre-
sents the stimulation to the motor nerve. Nei-
ther treatment has a significant effect on
excitatory junctional current (EJC) ampli-
tudes in control animals (control shown in
Elav-GAL4/). In contrast, taxol increases
EJC amplitudes in animals neurally overex-
pressing D-Spastin (Elav-GAL4; UAS-Dspas-
tin; compare black [mock] to red [taxol]), and
nocodazole decreases EJC amplitudes in ani-
mals with reduced D-Spastin (Elav-GAL4;
UAS-Dspastin RNAi; compare black [mock]
to blue [nocodazole]).
(B) Quantification of EJC amplitudes from the
experiments shown above. Note that noco-
dazole has no effect on synaptic function in
D-Spastin overexpressing animals, and taxol
does not effect neurotransmission during
RNAi expression (all n 
 4).
types, including both muscles and neurons, where it gated in an effort to identify a causative mechanism to
account for spastin-mediated HSP disease. Most impor-is present throughout the cell but undetectable in the
nucleus. These findings support the conclusion that tantly, misregulation of synaptic function in both the
loss and overexpression of Dspastin is rescued by phar-Spastin is a cytoplasmic protein, in contrast to some
previous reports that mammalian Spastin is a nuclear macologically modifying microtubule stability, as appro-
priate to counter the observed changes in microtubuleprotein [27]. Consistent with recent RNA in situ data in
the Drosophila embryo [24], D-Spastin protein is highly stability in both mutant conditions. Taken together,
these results strongly suggest that D-Spastin acts lo-enriched in neurons, and the protein is particularly abun-
dant in the presynaptic bouton compartments in synap- cally in the synapse to control microtubule stability and
the cytoskeletal compartmentalization of functional syn-tic connections. Strongly driven Dspastin RNAi results
in pupal lethality, showing that the gene is essential for aptic domains, and that this regulation plays a critical
role both in maintaining the synapse and in modulat-viability. Strongly driven Dspastin overexpression causes
cell death and neurodegeneration, showing that Dspas- ing the synaptic efficacy dictating neurotransmission
strength.tin gene dosage must be carefully controlled. Up- or
downregulation of Dspastin dosage results in striking
alterations in synaptic morphology and function. Tar- Microtubule Stability and Synaptic Mechanism
The elaboration of synaptic architecture, determininggeted removal of D-Spastin from neurons causes the
loss of synaptic area but, paradoxically, strengthened both the maintenance and extent of synaptic area, is
well documented to be microtubule dependent. At theneurotransmission. In contrast, overexpression of D-Spas-
tin in neurons reduces synaptic efficacy. As predicted Drosophila NMJ, multiple known regulators of microtu-
bule stability have been shown to modulate the size andby previous in vitro studies in mammals [12], Drosophila
Spastin closely regulates the stability of the neuronal complexity of the terminal arbor [14, 16–18, 34, 35]. The
current study shows that D-Spastin has a positive role inmicrotubule cytoskeleton in vivo. Loss of D-Spastin
leads to a dramatic increase in stabilized microtubules, maintaining the synapse by encouraging growth through
increasing the dynamic instability of microtubules. Thiswhich, in the synaptic terminal, inappropriately ramify
beyond their normal axonal compartments into the syn- conclusion is consistent with previous results showing
that synaptic terminals with stabilized microtubules areaptic boutons. Overexpression of D-Spastin causes an
erosion of the stabilized microtubule network. These less prone to branching and budding [17]. The hypothe-
sis is that proteins that stabilize microtubules shouldresults indicate that D-Spastin acts as a negative regula-
tor of microtubule stability. The relationship between inhibit synaptic growth, whereas proteins that destabi-
lize microtubules should facilitate synaptic growth.neuronal function and microtubule stability was investi-
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D-Spastin would therefore be predicted to promote syn- Mechanistic Insights into Hereditary
Spastic Paraplegia Diseaseaptic growth by destabilizing microtubules. The bio-
Hereditary Spastic Paraplegias are linked to multiplechemical action of Spastin in destabilizing microtubules,
genetic loci-encoding proteins apparently involved inwhich has been shown previously in mammalian cell
disparate cellular activities. However, one prominentlyculture [12], and the results here that D-Spastin destabi-
affected cellular mechanism appears to be alterationlizes microtubules within individual Drosophila synaptic
in microtubule cytoskeleton formation, stability, and/orterminals in situ strongly corroborates this hypothesis.
function. Specifically, well over half of all HSP diseaseThe effects on synaptic growth may have a com-
cases are linked to microtubule motor proteins (e.g.,pounding influence on synaptic function. However, we
KIF5A) or other proteins with microtubule-interactingobserve an inverse relationship between changes in syn-
domains (e.g., Spartin, Paraplegin, and Spastin) [4,aptic area and synaptic transmission strength after
7–11]. The most commonly mutated gene to cause HSPmanipulation of D-Spastin dosage. Knockdown of
is Spastin, making it the obvious choice to model theD-Spastin results in much smaller (area reduced50%)
mechanistic defects caused by loss of function of thisbut much stronger (EJC amplitude increased 50%)
suite of related microtubule-interacting proteins. ThisNMJ synapses. The increase in synaptic function may
study shows for the first time that Spastin is enrichedbe an overcompensation for the synaptic size [29], or
at the synapse, controlling both functional processesthese two synaptic parameters may be misregulated
driving synaptic transmission, as well as developmentalcompletely independently [30, 31]; however, the interde-
pathways determining synaptic growth and mainte-pendency of these data is unclear. Independent regula-
nance. Alteration in microtubule stability locally at thetion of synaptic growth and efficacy has been shown
synapse appears to be a primary consequence that fol-repeatedly during the course of analyzing Drosophila
lows changes in Spastin dosage, consistent with themutations in several genes [37, 38]. The fact that oppos-
hypothesis that Spastin is a negative regulator of theing defects in synaptic transmission caused by either
microtubule cytoskeleton stability. By extension, it isDspastin knockdown or overexpression can be rescued
likely that misregulation of microtubule stability is thewith acute pharmacological treatments to counter the
primary cause of HSP disease, both in the 40% of dis-misregulation of microtubule dynamics suggests that
ease cases directly associated with mutations in theD-Spastin plays a direct role in modulating synaptic
spastin (SPG4) gene as well as cases linked to Atlastin,efficacy, independent from a separable role in modulat-
Spartin, Paraplegin, and related proteins. This mecha-ing synaptic growth and architecture.
nistic insight suggests that therapeutic targets aimedSynaptic function appears sensitive to the stability of
at the mechanism of microtubule dynamic instability arethe microtubule cytoskeleton. The exact nature of this
likely to prove effective in the treatment of Hereditarydependency is unclear, since stabilized microtubules
Spastic Paraplegia disease.are normally tightly restricted to axons and interbouton
connectives and excluded from presynaptic boutons. Experimental Procedures
One obvious possibility is that alteration of microtubule
stability influences the microtubule-dependent trans- Transgenic Flies
Total RNA from adult Drosophila heads was purified with Trizolport of proteins or organelles required for maintained
reagent (Invitrogen Corporation). The Dspastin full-length cDNA wassynaptic vesicle cycling and neurotransmitter release
obtained by RT-PCR by using the following primers 5-GCAATGCG
[24]. D-Spastin protein is normally tightly restricted to GCCGCACCGATTTGGCTTACAAGGA-3 and 5-CGTATTCTAGAC
synaptic boutons, which lack stabilized microtubules, TTAAGGGCGAAAAACATGG-3. For overexpression studies, a UAS-
and absent from interbouton connectives, which contain Dspastin construct was generated by introducing the entire Dspastin
cDNA in the transformation vector pUAST. The construct for induc-stabilized microtubules. It is tempting to speculate that
ible RNA interference (RNAi-Dspastin) was made according to pre-the D-Spastin domains determine the domains of stabi-
viously described procedures [36]. Genomic and cDNA fragmentslized versus unstabilized Tubulin within the synaptic were amplified by using the following primer pairs: genomic, 5-
arbor. Changes in D-Spastin levels not only regulate the TGAAATCGTGGTGCAGAATTCC-3 and 5-AGCTGCGGCCGCCT
abundance of stabilized microtubules but also deter- AAAAAGGAAG AAGATTGGTTATGGT-3; cDNA, 5-ATACTCTAGA
TTCCTCCAAGGAGCAACAGCA-3 and 5-GACAGCGGCCGCCCGmine their synaptic localization; loss of D-Spastin
TAA AGAGTTCCGGTCGGACGGAG-3. The final genomic-cDNA fu-causes stabilized microtubules to inappropriately in-
sion fragment was cloned in the pUAST transformation vector. Sev-vade synaptic boutons. The defects in neurotransmis-
eral independent lines of transgenic animals carrying UAS-Dspastin
sion in both loss and gain of D-Spastin conditions were or UAS-RNAi-Dspastin were generated by standard microinjection
strikingly rescued by pharmacologically shifting micro- of Drosophila embryos.
tubule dynamics away from the aberrant condition. In-
Control Genotypesterestingly, the microtubule-modulating drugs that ef-
All experiments labeled as “control” were performed by using trans-fectively restore aberrant neurotransmission in both
genic animals with the appropriate control genotype. While only one
Dspastin loss and overexpression mutants do not signif- example is shown, all genetic controls, in addition to experimental
icantly alter basal synaptic function in wild-type syn- genotypes (UAS-Dspastin/Elav-GAL4 or UAS-Dspastin-RNAi/Elav-
apses [23]. This shows that alteration in D-Spastin levels Gal4) were performed for the following genotypes: UAS-Dspastin/
(third chromosome); UAS-Dspastin-RNAi/ (second chromosome),is first required to prime the system for responsiveness.
and Elav-Gal4/ (first chromosome). When possible only femalesIt appears that alterations in Dspastin dosage lead to a
were used to avoid hemizygous phenotypes in Elav-Gal4/Y animals.constitutive shifts in the microtubule equilibrium, which
makes the synapse acutely sensitive to additional RT-PCR
changes in microtubule stability. Why this should be the The presence of the Dspastin messenger RNA in flies expressing
RNAi-Dspastin driven by Tubulin-GAL4 was monitored by RT-PCR.case is presently unclear.
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Briefly, total RNA was extracted from individual RNAi-Dspastin/ technical advice; and Yong Zhang, Peter Hedera, and Jeff Rohr-
bough for comments on the manuscript. We thank Hugo BellenTubulin-GAL4 mutants and RNAi-Dspastin/SM6a controls. Approxi-
mately 2 g of total RNA were used for oligo-dT primed reverse (Baylor University) for the Synaptotagmin antibody. N.T. was sup-
ported by a National Institutes of Health (NIH) Training Grant to thetranscription. The cDNA thus generated was used to amplify the
Dspastin cDNA and a control cDNA (CG7263). Program in Developmental Biology at Vanderbilt University. This
study was supported by Telethon grant TCP.00059 to A.D. and NIH
grant RO1 NS41740 to K.B.Generation of Anti-D-Spastin Antibody
A synthetic peptide corresponding to amino acid residues 64–85
(GSSSNRRSPGSSPDGDDDTTTT) of D-Spastin was used for immu- Received: December 8, 2003
nization. The peptide with one cysteine added at the N terminus Revised: April 13, 2004
was conjugated with Limulus polyphemus hemocyanine and in- Accepted: April 28, 2004
jected into two guinea pigs, following standard immunization proto- Published: July 13, 2004
cols (Biogenes, Berlin, Germany).
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